ATE361091T1 - Behandlung von unfruchtbarkeit - Google Patents

Behandlung von unfruchtbarkeit

Info

Publication number
ATE361091T1
ATE361091T1 AT00906177T AT00906177T ATE361091T1 AT E361091 T1 ATE361091 T1 AT E361091T1 AT 00906177 T AT00906177 T AT 00906177T AT 00906177 T AT00906177 T AT 00906177T AT E361091 T1 ATE361091 T1 AT E361091T1
Authority
AT
Austria
Prior art keywords
woman
infertility
treatment
hormone
vitro
Prior art date
Application number
AT00906177T
Other languages
English (en)
Inventor
Christian Grondahl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE361091T1 publication Critical patent/ATE361091T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ceramic Capacitors (AREA)
AT00906177T 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit ATE361091T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900256 1999-02-24
US13066299P 1999-04-23 1999-04-23
DKPA199901307 1999-09-16

Publications (1)

Publication Number Publication Date
ATE361091T1 true ATE361091T1 (de) 2007-05-15

Family

ID=27220547

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906177T ATE361091T1 (de) 1999-02-24 2000-02-23 Behandlung von unfruchtbarkeit

Country Status (12)

Country Link
US (1) US6281013B1 (de)
EP (1) EP1156821B1 (de)
JP (1) JP2002537348A (de)
KR (1) KR20010093276A (de)
AT (1) ATE361091T1 (de)
AU (1) AU2794000A (de)
CA (1) CA2363074A1 (de)
CZ (1) CZ20012968A3 (de)
DE (1) DE60034662T2 (de)
ES (1) ES2286008T3 (de)
HU (1) HUP0200079A3 (de)
WO (1) WO2000050065A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1353617A (zh) * 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
AU2002239902A1 (en) * 2001-01-12 2002-09-12 Napoli, Llc. Intra-uterine devices and method of use
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
WO2003076600A2 (en) 2002-03-08 2003-09-18 Mcgill University In vitro maturation of immature human oocytes
RU2307687C2 (ru) * 2003-03-05 2007-10-10 Санкт-Петербургская медицинская академия последипломного образования Применение фотогемотерапии в программе подготовки пациентов к экстракорпоральному оплодотворению
EP1550447A1 (de) * 2004-01-02 2005-07-06 Schering Aktiengesellschaft Menstruationszykluskontrolle und Verbesserung der weiblichen Empfängnisrate
EP1765983A4 (de) 2004-05-17 2008-10-22 Gen Hospital Corp Verfahren und zusammensetzungen zur herstellung von stammzellen aus von knochenmark abgeleiteten keimbahn-stammzellen
PL2827150T3 (pl) 2009-08-22 2021-05-31 The Board Of Trustees Of The Leland Stanford Junior University Obrazowanie i ocena zarodków, oocytów i komórek macierzystych
CA2812776C (en) 2010-09-27 2022-05-17 Auxogyn, Inc. Apparatus, method, and system for the automated imaging and evaluation of embryos, oocytes, and stem cells
CA2827945C (en) 2011-02-23 2021-10-12 The Board Of Trustees Of The Leland Stanford Junior University Methods of detecting aneuploidy in human embryos
CN106350479A (zh) 2011-04-14 2017-01-25 通用医疗公司 用于自体种系线粒体能量转移的组合物和方法
EA201490050A1 (ru) 2011-06-29 2014-07-30 Зе Дженерэл Хоспитэл Корпорейшн Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток
US20150272622A1 (en) * 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
EP2855694B1 (de) 2012-05-31 2018-12-26 Progyny, Inc. In-vitro-verfahren zur vorhersage von blastozysten
US10241108B2 (en) 2013-02-01 2019-03-26 Ares Trading S.A. Abnormal syngamy phenotypes observed with time lapse imaging for early identification of embryos with lower development potential
ES2837840T3 (es) 2014-03-20 2021-07-01 Ares Trading Sa Medida cuantitativa de la cinética de desarrollo de la morfología de mórula y blastocisto humanos
US20240034981A1 (en) 2020-10-22 2024-02-01 The Regents Of The University Of California Devices and Methods for Evaluating the Viability of Embryos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
CA2224866A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
TR199902873T2 (xx) * 1997-06-04 2000-04-21 Akzo Nobel N.V. Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri.
US5866599A (en) * 1997-06-06 1999-02-02 Basf Aktiengesellschaft Fungicidal mixtures

Also Published As

Publication number Publication date
WO2000050065A1 (en) 2000-08-31
HUP0200079A3 (en) 2002-06-28
DE60034662T2 (de) 2008-01-03
US6281013B1 (en) 2001-08-28
CZ20012968A3 (cs) 2002-01-16
HUP0200079A2 (hu) 2002-05-29
AU2794000A (en) 2000-09-14
JP2002537348A (ja) 2002-11-05
ES2286008T3 (es) 2007-12-01
CA2363074A1 (en) 2000-08-31
EP1156821A1 (de) 2001-11-28
DE60034662D1 (de) 2007-06-14
EP1156821B1 (de) 2007-05-02
KR20010093276A (ko) 2001-10-27

Similar Documents

Publication Publication Date Title
ATE361091T1 (de) Behandlung von unfruchtbarkeit
DE69022722D1 (de) Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
ATE293989T1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
DE69412807D1 (de) Einrichtung zur abgabe von elektrischen impulsen für die behandlung biologischer gewebe
DE69735514D1 (de) Vorrichtung zur Behandlung von Halbleiterscheiben
DE60138553D1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
ES2009948A6 (es) Procedimiento de preparacion de una proteina procedente de una hormona estimulante folicular urinaria, mediante proceso de inmunopurificacion de un concentrado urinario post-menopausico.
DK0736039T3 (da) Forbindelser med væksthormon-frigivende egenskaber
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
EA200300944A1 (ru) Ацилированные пиперидиновые производные в качестве агонистов рецептора-4 меланокортина
DE69533991D1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
ATE424209T1 (de) Verwendung von gnrh-agonisten zur unterstützung der lutealphase während einer unfruchtbarkeitsbehandlung
DE69130987D1 (de) Vorrichtung zur Behandlung von Halbleiter-Plättchen
EA200400427A1 (ru) Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичников
Demanno et al. Steroid-induced final maturation in brook trout (Salvelinus fontinalis) oocytes in vitro: the effects of forskolin and phosphodiesterase inhibitors
DE60018707D1 (de) Anti-androgene und verfahren zur behandlung von krankheiten
UA66850C2 (uk) Спосіб лікування безпліддя
DE69927154D1 (de) Vorrichtung und verfahren zur behandlung von erektionsstörungen
WO2003076600A3 (en) In vitro maturation of immature human oocytes
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
RU2004101971A (ru) Фармацевтические композиции, которые ингибируют пролиферацию аденом гипофиза, и способ их применения
DE60132436D1 (de) Retinolsäure-rezeptor beta-2 und gentherapievektoren für die behandlung von neurologischen erkrankungen
EA200000689A1 (ru) Способ получения пароксетин гидрохлорида
TR199900480T2 (xx) Kristalin farmas�tik �r�n.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties